In February 2012, a conference titled “Management of Benzodiazepines in Medication-Assisted Treatment” was held in Philadelphia, PA. It was sponsored by Philadelphia DBHIDS, IRETA, Community Care Behavioral Health, and SAMHSA.
Conference description: Published literature, treatment protocols and guidelines demonstrate variation and inconsistency in clinical practice regard benzodiazepine management in medication-assisted treatment. In recognition of a need to establish evidence-based best practice recommendations for the safe and effective use of benzodiazepines in combination with opioid medications, the conference sought to identify current practices and outstanding questions. Regional and national experts offered research updates, pinpointed questions and kicked off a project to develop a working set of guidelines on the management of benzodiazepines in the context of medication-assisted addiction treatment.
Conference Slideshow Presentations
- Jane Maxwell – Epidemiology Morbidity and Mortality for Benzo Use
- James Schuster – Rates of Benzodiazepine Use in MAT from CCBH Counties
- Matthew Hurford – Rates of Benzodiazepine Use in MAT from CBH Counties
- Laura McNicholas – Clinical Management of Benzodiazepine Abuse
- Louis E Baxter – Benzodiazepine Prescribing In Primary Care Settings: Issue for Concern?
- Peter DeMaria – Psychiatry and Co-Occurring Disorders
- Laura Murray – Benzodiazepines & Buprenorphine in the OBOT Setting
- Karol Kaltenbach – Benzodiazepines and the Pregnant Patient, Special Challenges
- Antoine Douiahy – Pharmacology (Drug-Drug Interactions)
- Abigail Kay – Treatment of Anxiety in the Methadone Maintained Patient
- Trusandra Taylor – Risk Management and Benzodiazepine Use
- Jan Kusserow – Benzodiazepine Use in MAT: Patient Education and Safety